Skip to main content
. 2021 Jan 1;13(1):e2021007. doi: 10.4084/MJHID.2021.007

Table 5.

Means (SD) of baseline SF-361 quality of life scores in SCD patients without and with macro and micro nutritional deficiencies versus control subjects.

Scores (norm) SCD patients with no macro or micro-nutrient deficiencies (n=20) SCD patients with macro or micro-nutrient deficiencies (n=42) P-value Control subjects (n=50) P value between SCD patients and controls
PF 84.05 ± 2.81 80.50 ± 3.19 <0.0001 90.10 ± 2.40 <0.0001**
RP 88.21± 1.71 86.83 ± 1.34 0.0013 90.48 ± 3.4 0.0008
BP 82.13 ± 2.42 80.21 ±2.25 <0.0001 84.63± 3.36 0.0002
GH 52.89 ± 2.37 50.25± 1.75 <0.0001 54.24± 3.11 0.0377*
VT 55.34 ± 2.33 53.21 ± 1.56 <0.0001 59.35 ± 3.617 0.0001**
SF 88.29 ± 2.18 86.83 ± 1.52 <0.0001 91.47 ± 3.9 <0.0001**
RE 83.97 ± 3.31 81.83 ± 3.76 0.006 88.53 ± 8.56 <0.0001**
MH 72.09 ± 3.18 71.79 ± 2.67 0.058 72.10 ± 4.3 0.3112
PCS 43.74 ± 1.54 41.04± 1.73 <0.0001 47.81 ± 2.7 <0.0001**
MCS 49.21 ± 1.72 49.01 ± 1.82 0.062 50.07 ± 1.11 0.0255

SF-36, short-form quality of life score with 36 questions. HRQoL: health- related quality of life. AC, activity; BP, bodily pain; EF, emotional function; FA, fatigue; GH, general health; MCS, Mental Component Summary Score; MH, mental health; PCS, Physical Component Summary Score; PF, physical functioning; RE, Role Emotional; RP, role physical; SF, social functioning; SS, systemic symptoms; VT, vitality; WO, worry.

*

Significant difference between the study groups (P<0.05).

**

Highly significant difference between the two study groups (P<0.01, 0.001).

Significant differences existed between patients with SCD and control subjects as well as well-nourished and undernourished SCD patients in all SF-36v2 domains except MH and MCs.